Adjuvant Treatment Modalities, Prognostic Factors, and Outcome of the Uterine Carcinosarcoma

Kahramanoglu I., DEMİRKIRAN F., TURAN H., BEŞE T. T., Cebi S., İLVAN Ş., ...Daha Fazla

JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, cilt.43, sa.1, ss.34-42, 2021 (ESCI) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 43 Sayı: 1
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1016/j.jogc.2020.06.021
  • Dergi Adı: JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, CINAHL, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.34-42
  • Anahtar Kelimeler: carcinosarcoma, mixed tumor, mullerian, uterine neoplasms, radiotherapy, STAGE-I, RADIATION-THERAPY, SURVIVAL, PATTERNS, LYMPHADENECTOMY, GUIDELINES, SARCOMA, UTERUS, IMPACT
  • İstanbul Üniversitesi Adresli: Evet

Özet

Objective: To determine the impact of adjuvant therapy and other factors associated with the recurrence and survival of patients with uterine carcinosarcoma (UCS).